{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:52:32Z","timestamp":1793267552213,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA053997"],"award-info":[{"award-number":["K23DA053997"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1734362"],"award-info":[{"award-number":["1734362"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.mcna.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T16:56:46Z","timestamp":1637600206000},"page":"131-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical Approaches to Cannabis"],"prefix":"10.1016","volume":"106","author":[{"given":"Deepika E.","family":"Slawek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna A.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo O.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2021.08.004_bib1","series-title":"Cannabis overview","author":"Hartman","year":"2021"},{"key":"10.1016\/j.mcna.2021.08.004_bib2","series-title":"Legal recreational states and DC","year":"2021"},{"key":"10.1016\/j.mcna.2021.08.004_bib3","series-title":"Procon.org. Legal medical marijuana states and DC","year":"2021"},{"key":"10.1016\/j.mcna.2021.08.004_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","article-title":"Cannabis use, attitudes, and legal status in the U.S.: a review","volume":"104","author":"Carliner","year":"2017","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib6","first-page":"1","article-title":"A\u00a0history of United States cannabis law","volume":"34","author":"Patton","year":"2020","journal-title":"J\u00a0L Health"},{"key":"10.1016\/j.mcna.2021.08.004_bib7","series-title":"The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","year":"2017"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.004_bib8","doi-asserted-by":"crossref","first-page":"e0224289","DOI":"10.1371\/journal.pone.0224289","article-title":"Has the \"M\" word been framed? Marijuana, cannabis, and public opinion","volume":"14","author":"Mikos","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.mcna.2021.08.004_bib9","series-title":"The mysterious history of \u2018marijuana\u2019. Code switch: word watch web site","author":"Thompson","year":"2013"},{"key":"10.1016\/j.mcna.2021.08.004_bib10","series-title":"Testimony: hemp production and the 2018 Farm Bill","author":"Abernethy","year":"2019"},{"key":"10.1016\/j.mcna.2021.08.004_bib11","article-title":"A\u00a0survey of state CBD & hemp regulation since the 2018 farm bill","author":"Schuman","year":"2020","journal-title":"Cannabis Industry J"},{"key":"10.1016\/j.mcna.2021.08.004_bib12","series-title":"CBD is booming. But US farmers struggle to keep up with demand for industrial hemp","author":"LaVito","year":"2019"},{"key":"10.1016\/j.mcna.2021.08.004_bib13","series-title":"Racially targeted arrests in the era of marijuana reform","article-title":"A\u00a0tale of two countries","year":"2020"},{"key":"10.1016\/j.mcna.2021.08.004_bib15","series-title":"The war of marijuana in black and white","year":"2013"},{"key":"10.1016\/j.mcna.2021.08.004_bib16","first-page":"7193740","article-title":"Availability of medical and recreational marijuana stores and neighborhood characteristics in Colorado","volume":"2016","author":"Shi","year":"2016","journal-title":"J\u00a0Addict"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/02791072.2011.587700","article-title":"Who are medical marijuana patients? Population characteristics from nine California assessment clinics","volume":"43","author":"Reinarman","year":"2011","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.mcna.2021.08.004_bib18","series-title":"2019 national survey of drug use and health (NSDUH) releases","year":"2019"},{"key":"10.1016\/j.mcna.2021.08.004_bib19","unstructured":"Hughes A, Lipari RN, Williams MR. Marijuana use and perceived risk of harm from marijuana use varies within and across states. In: The CBHSQ report. Rockville (MD): 2013. p. 1\u201319."},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13643-017-0541-4","article-title":"Structural barriers in access to medical marijuana in the USA\u2014a systematic review protocol","volume":"6","author":"Valencia","year":"2017","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000512342","article-title":"Demographics, perceptions, and use of medical marijuana among patients in Florida","volume":"4","author":"Rosenthal","year":"2020","journal-title":"Med Cannabis Cannabinoids"},{"key":"10.1016\/j.mcna.2021.08.004_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apha.2017.03.004","article-title":"Cannabis pharmacology: the usual suspects and a few promising leads","volume":"80","author":"Russo","year":"2017","journal-title":"Adv Pharmacol"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1574884711666160418105339","article-title":"Endocannabinoid system: a multi-facet therapeutic target","volume":"11","author":"Kaur","year":"2016","journal-title":"Curr Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review","volume":"90","author":"Svizenska","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-019-00978-2","article-title":"A\u00a0randomised controlled trial of vaporised \u0394(9)-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects","volume":"269","author":"Solowij","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.004_bib28","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"issue":"16","key":"10.1016\/j.mcna.2021.08.004_bib29","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","article-title":"Medical use of cannabinoids","volume":"78","author":"Fraguas-Sanchez","year":"2018","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","article-title":"An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics","volume":"46","author":"Johnson","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A\u00a0systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.004_bib32","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"24","key":"10.1016\/j.mcna.2021.08.004_bib33","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M17-0155","article-title":"The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review","volume":"167","author":"Nugent","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1360-0443.2010.03139.x","article-title":"The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences","volume":"106","author":"Temple","year":"2011","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1377\/hlthaff.2018.05266","article-title":"Qualifying conditions of medical cannabis license holders in the United States","volume":"38","author":"Boehnke","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/dmcn.14165","article-title":"Cannabinoids for the treatment of spasticity","volume":"61","author":"Nielsen","year":"2019","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09593980600724188","article-title":"Ashworth scales are unreliable for the assessment of muscle spasticity","volume":"22","author":"Ansari","year":"2006","journal-title":"Physiother Theor Pract"},{"key":"10.1016\/j.mcna.2021.08.004_bib40","series-title":"The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","year":"2017"},{"issue":"29\u201330","key":"10.1016\/j.mcna.2021.08.004_bib41","first-page":"495","article-title":"The therapeutic potential of cannabis and cannabinoids","volume":"109","author":"Grotenhermen","year":"2012","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.004_bib42","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"21","key":"10.1016\/j.mcna.2021.08.004_bib43","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","volume":"24","author":"Strasser","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.mcna.2021.08.004_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1534735419881498","article-title":"The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: pilot study","volume":"18","author":"Bar-Sela","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.mcna.2021.08.004_bib45","series-title":"FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy","year":"2018"},{"issue":"21","key":"10.1016\/j.mcna.2021.08.004_bib46","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.mcna.2021.08.004_bib47","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2021.08.004_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2018.07.020","article-title":"Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study","volume":"87","author":"Szaflarski","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.mcna.2021.08.004_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yebeh.2019.04.008","article-title":"fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy","volume":"96","author":"Allendorfer","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14581\/jer.17012","article-title":"Cannabinoids in the treatment of epilepsy: hard evidence at last?","volume":"7","author":"Perucca","year":"2017","journal-title":"J\u00a0Epilepsy Res"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","article-title":"Cannabis and mental illness: a review","volume":"269","author":"Lowe","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.mcna.2021.08.004_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.004_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","article-title":"Preliminary, open-label, pilot study of add-on oral \u03949-tetrahydrocannabinol in chronic post-traumatic stress disorder","volume":"34","author":"Roitman","year":"2014","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.004_bib56","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jamainternmed.2018.0266","article-title":"Association between US state medical cannabis laws and opioid prescribing in the medicare part D population","volume":"178","author":"Bradford","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1377\/hlthaff.2016.1135","article-title":"Medical marijuana laws may be associated with a decline in the number of prescriptions for medicaid enrollees","volume":"36","author":"Bradford","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib59","first-page":"739","article-title":"Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"Boehnke","year":"2016","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.mcna.2021.08.004_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jhealeco.2017.12.007","article-title":"Do medical marijuana laws reduce addictions and deaths related to pain killers?","volume":"58","author":"Powell","year":"2018","journal-title":"J\u00a0Health Econ"},{"issue":"26","key":"10.1016\/j.mcna.2021.08.004_bib61","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1073\/pnas.1903434116","article-title":"Association between medical cannabis laws and opioid overdose mortality has reversed over time","volume":"116","author":"Shover","year":"2019","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib62","first-page":"295","article-title":"Medical marijuana users are more likely to use prescription drugs medically and nonmedically","volume":"12","author":"Caputi","year":"2018","journal-title":"J\u00a0Addict Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib64","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1183\/09031936.00051108","article-title":"Doubts about the role of cannabis in causing lung cancer","volume":"32","author":"Sewell","year":"2008","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/AIA.0b013e3181dd4f53","article-title":"The perioperative implications of tobacco, marijuana, and other inhaled toxins","volume":"49","author":"Bryson","year":"2011","journal-title":"Int Anesthesiol Clin"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.004_bib66","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ejim.2007.06.031","article-title":"Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis","volume":"19","author":"Khiabani","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib67","doi-asserted-by":"crossref","first-page":"e009986","DOI":"10.1136\/bmjopen-2015-009986","article-title":"Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis","volume":"6","author":"Gunn","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.mcna.2021.08.004_bib68","series-title":"Medications for opioid use disorder save lives","author":"Mancher","year":"2019"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib70","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/resp.12298","article-title":"Cannabis smoking and respiratory health: consideration of the literature","volume":"19","author":"Gates","year":"2014","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/cpt197314148","article-title":"Pharmacology of orally administered 9 -tetrahydrocannabinol","volume":"14","author":"Perez-Reyes","year":"1973","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib72","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","article-title":"Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women","volume":"34","author":"Wall","year":"1983","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/clpt.1980.181","article-title":"Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking","volume":"28","author":"Ohlsson","year":"1980","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib74","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007691-200608000-00010","article-title":"Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids","volume":"28","author":"Goodwin","year":"2006","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jchromb.2003.09.022","article-title":"Validated method for the simultaneous determination of Delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization","volume":"798","author":"Gustafson","year":"2003","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.004_bib76","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7326\/M18-2809","article-title":"Acute illness associated with cannabis use, by route of exposure: an observational study","volume":"170","author":"Monte","year":"2019","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2014.17057","article-title":"The implications of marijuana legalization in Colorado","volume":"313","author":"Monte","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.mcna.2021.08.004_bib78","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.004_bib79","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mcna.2021.08.004_bib80","article-title":"Can prescribed medical cannabis use reduce the use of other more harmful drugs?","volume":"6","author":"Gittins","year":"2020","journal-title":"Drug Sci Policy L"},{"issue":"7374","key":"10.1016\/j.mcna.2021.08.004_bib81","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.325.7374.1195","article-title":"Cannabis use and mental health in young people: cohort study","volume":"325","author":"Patton","year":"2002","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.004_bib82","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib83","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophr Bull"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.004_bib84","first-page":"879","article-title":"Adverse health effects of marijuana use","volume":"371","author":"Volkow","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.004_bib85","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum Psychopharmacol"},{"issue":"1 Suppl","key":"10.1016\/j.mcna.2021.08.004_bib86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J\u00a0Psychopharmacol"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J\u00a0Psychopharmacol"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0269881111408956","article-title":"The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications","volume":"26","author":"Viveros","year":"2012","journal-title":"J\u00a0Psychopharmacol"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib89","doi-asserted-by":"crossref","first-page":"17m11977","DOI":"10.4088\/JCP.17m11977","article-title":"One month of cannabis abstinence in adolescents and young adults is associated with improved memory","volume":"79","author":"Schuster","year":"2018","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.004_bib90","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/gut.2003.036350","article-title":"Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse","volume":"53","author":"Allen","year":"2004","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2021.08.004_bib91","doi-asserted-by":"crossref","first-page":"e13606","DOI":"10.1111\/nmo.13606","article-title":"Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome","volume":"31","author":"Venkatesan","year":"2019","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib92","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib93","first-page":"571","article-title":"Cannabis hyperemesis syndrome: an update on the pathophysiology and management","volume":"33","author":"Perisetti","year":"2020","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib94","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/phar.1931","article-title":"Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review","volume":"37","author":"Richards","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib95","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1183\/20734735.020418","article-title":"Marijuana and the lung: hysteria or cause for concern?","volume":"14","author":"Ribeiro","year":"2018","journal-title":"Breathe (Sheff)"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib96","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chest.2018.05.005","article-title":"Marijuana and lung disease","volume":"154","author":"Tashkin","year":"2018","journal-title":"Chest"},{"issue":"36","key":"10.1016\/j.mcna.2021.08.004_bib97","doi-asserted-by":"crossref","first-page":"787","DOI":"10.15585\/mmwr.mm6836e2","article-title":"Severe pulmonary disease associated with electronic-cigarette-product use - Interim guidance","volume":"68","author":"Schier","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.004_bib98","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1911614","article-title":"Pulmonary illness related to E-cigarette use in Illinois and Wisconsin - final report","volume":"382","author":"Layden","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.004_bib99","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJMe1912032","article-title":"Vaping-induced acute lung injury","volume":"382","author":"Christiani","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1378\/chest.112.2.319","article-title":"Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and\/or tobacco","volume":"112","author":"Fligiel","year":"1997","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib101","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1164\/ajrccm.156.5.9704146","article-title":"Marijuana and cocaine impair alveolar macrophage function and cytokine production","volume":"156","author":"Baldwin","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib102","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/368370","article-title":"Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine","volume":"187","author":"Shay","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib103","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ijc.29036","article-title":"Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium","volume":"136","author":"Zhang","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib104","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1183\/09031936.00065707","article-title":"Cannabis use and risk of lung cancer: a case-control study","volume":"31","author":"Aldington","year":"2008","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.15288\/jsad.2012.73.820","article-title":"Measures of substance consumption among substance users, DSM-IV abusers, and those with DSM-IV dependence disorders in a nationally representative sample","volume":"73","author":"Moss","year":"2012","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib106","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1360-0443.2007.02064.x","article-title":"The natural course of cannabis use, abuse and dependence during the first decades of life","volume":"103","author":"Perkonigg","year":"2008","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.004_bib107","doi-asserted-by":"crossref","first-page":"e76635","DOI":"10.1371\/journal.pone.0076635","article-title":"The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study","volume":"8","author":"Degenhardt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mcna.2021.08.004_bib108","series-title":"Center for Behavioral Health Statistics and Quality","author":"Hedden","year":"2015"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib109","article-title":"Psychosocial interventions for cannabis use disorder","volume":"2016","author":"Gates","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2017.212","article-title":"The current state of pharmacological treatments for cannabis use disorder and withdrawal","volume":"43","author":"Brezing","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib111","first-page":"30","article-title":"N-acetylcysteine: a potential treatment for substance use disorders","volume":"17","author":"Tomko","year":"2018","journal-title":"Curr Psychiatr"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.004_bib112","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.2012.12010055","article-title":"A\u00a0double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents","volume":"169","author":"Gray","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib113","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-019-05384-z","article-title":"Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder","volume":"237","author":"Tomko","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12229-015-9157-3","article-title":"Evolution and classification of cannabis sativa (marijuana, hemp) in relation to human utilization","volume":"81","author":"Small","year":"2015","journal-title":"Bot Rev"},{"key":"10.1016\/j.mcna.2021.08.004_bib115","series-title":"Marinol (dronabinol) capsules, for oral use","year":"2017"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.004_bib116","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S2215-0366(16)30208-5","article-title":"Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys","volume":"3","author":"Compton","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.1992.100","article-title":"Characterization of the absorption phase of marijuana smoking","volume":"52","author":"Huestis","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mcna.2021.08.004_bib118","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2018.12.021","article-title":"A\u00a0preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids","volume":"295","author":"H\u00e4dener","year":"2019","journal-title":"Forensic Sci Int"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.004_bib119","first-page":"e7033","article-title":"Cannabis butane hash oil dabbing induced lung injury mimicking atypical pneumonia","volume":"12","author":"Stephens","year":"2020","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.004_bib120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2131\/jts.40.797","article-title":"Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing","volume":"40","author":"Raber","year":"2015","journal-title":"J\u00a0Toxicol Sci"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.004_bib121","first-page":"e10311","article-title":"A\u00a0little dab will do: a case of cannabis-induced psychosis","volume":"12","author":"Rossi","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.mcna.2021.08.004_bib122","doi-asserted-by":"crossref","first-page":"802649","DOI":"10.5402\/2012\/802649","article-title":"Evaluation of the effects of sativex (THC BDS: CBD BDS) on inhibition of spasticity in a chronic relapsing experimental allergic autoimmune encephalomyelitis: a model of multiple sclerosis","volume":"2012","author":"Hilliard","year":"2012","journal-title":"ISRN Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.004_bib123","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1373\/clinchem.2010.152439","article-title":"Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration","volume":"57","author":"Karschner","year":"2011","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.004_bib124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1300\/J175v03n04_01","volume":"3","author":"Guy","year":"2004","journal-title":"J\u00a0Cannabis Ther"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0091-3057(91)90353-4","article-title":"Rectal bioavailability of delta-9-tetrahydrocannabinol from various esters","volume":"40","author":"Elsohly","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.004_bib126","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0091-3057(93)90194-X","article-title":"Bypassing the first-pass effect for the therapeutic use of cannabinoids","volume":"44","author":"Mattes","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.004_bib127","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jps.20036","article-title":"In\u00a0vitro\/in\u00a0vivo correlation studies for transdermal delta 8-THC development","volume":"93","author":"Valiveti","year":"2004","journal-title":"J\u00a0Pharm Sci"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:14:34Z","timestamp":1777425274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0025712521001127"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.004","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Approaches to Cannabis","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}